This reaction necessary to allow a neuron to return to its resting state after activation.
Acetylcholine was the first neurotransmitter be be identified. It was discovered by Henry Hallett Dale in 1914 and its existence was later confirmed by Otto Loewi. Both individuals were awarded the Nobel Prize in Physiology/Medicine in 1936 for their discovery.
There is a resultant cholinergic deficit which contributes to the cognitive impairment of patients with this disease.
An interesting article can be found on "How Stuff Works" about how Acetycholine receptors work (and how nicotine is implicated in this process).
Although many believe this ‘cholinergic hypothesis’ to be important, others feel it represents a less significant component of the disease process. Many other neurotransmitters are affected in AD, and the relative importance of each in relation to clinical findings has not been fully elucidated.
No hay comentarios:
Publicar un comentario